M11.219 Other chondrocalcinosis, unspecified shoulder

Name of the Condition

• Other chondrocalcinosis, unspecified shoulder

Summary

Other chondrocalcinosis, unspecified shoulder refers to the deposition of calcium-containing crystals in the shoulder joint tissues, excluding calcium pyrophosphate dihydrate (CPPD) or hydroxyapatite. This condition causes joint inflammation, pain, and potential structural damage, often mimicking other arthritic diseases. Diagnosis typically requires identifying the specific crystal type through joint fluid analysis or tissue sampling.

Causes

Other chondrocalcinosis, unspecified shoulder is caused by the deposition of non-CPPD, non-hydroxyapatite calcium crystals (e.g., calcium oxalate, calcium phosphate) in the shoulder’s cartilage, synovium, or surrounding tissues. The exact triggers vary but may include metabolic imbalances, genetic factors, or underlying systemic conditions. Crystal formation provokes an inflammatory response, leading to joint symptoms.

Risk Factors

• Metabolic disorders (e.g., hyperoxaluria, hypophosphatasia).
• Chronic kidney disease or dialysis.
• Genetic predisposition to crystal formation.
• Exposure to certain medications or toxins.
• Shoulder trauma or surgery.

Symptoms

• Shoulder pain, swelling, and stiffness.
• Warmth and redness over the affected joint.
• Reduced range of motion.
• Recurrent episodes of inflammation.
• Systemic symptoms (e.g., fever) in severe cases.

Diagnosis

Diagnosis involves clinical evaluation, imaging (e.g., X-ray, ultrasound), and sometimes crystal identification in joint fluid or tissue. Laboratory tests may assess metabolic or systemic conditions contributing to crystal formation.

Treatment Options

Treatment focuses on managing inflammation and pain, often with nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids. Physical therapy may improve range of motion. Addressing underlying metabolic or systemic conditions is important for long-term management.

Prognosis and Follow-Up

Prognosis depends on the extent of joint damage and response to treatment. Regular follow-up helps monitor symptoms, joint function, and potential complications. Early intervention may slow disease progression.

Complications

• Chronic joint damage or degenerative changes.
• Recurrent inflammation or flare-ups.
• Reduced shoulder mobility or function.
• Potential for secondary osteoarthritis.

Lifestyle & Prevention

• Maintain a balanced diet to support metabolic health.
• Avoid shoulder overuse or repetitive strain.
• Manage underlying conditions (e.g., kidney disease) with medical guidance.
• Use protective measures during activities to reduce injury risk.

When to Seek Professional Help

Seek care if shoulder pain is severe, persistent, or worsening; if swelling, redness, or fever occurs; or if mobility is significantly limited. Prompt evaluation is important for accurate diagnosis and treatment.

Tips for Medical Coders

Document the shoulder involvement as unspecified, as the code M11.219 applies when the shoulder is affected but not specified as left or right. Include details on crystal type (if identified) and any underlying metabolic or systemic conditions to support clinical correlation. Ensure documentation aligns with the absence of CPPD or hydroxyapatite crystal involvement.